Core Insights - The 2025 Global Coastal Forum on Marine Drugs and Bioproducts was held in Yancheng, focusing on the theme of "Exploring Marine Active Substances Empowering the Pharmaceutical and Health Industry" [1][2] - Jiangsu Province aims to enhance the high-quality development of the marine economy, with a target of exceeding 1 trillion yuan in marine industry value by 2024, although the added value of marine drugs and bioproducts remains below 10 billion yuan [1] - Yancheng is positioned as a pioneer in high-quality coastal development, with a solid industrial foundation and active capital markets, particularly in the offshore wind power sector [2] Industry Developments - Jiangsu Development and Reform Commission plans to build a diversified high-value industry system encompassing deep processing of marine medicine, innovative research and development in marine health industries, and upgrades in marine health foods [1] - The conference featured discussions on the current research status and future directions of marine biological drugs, highlighting the collaborative efforts among various academic institutions [2] - The establishment of innovation centers and talent recruitment initiatives in collaboration with local government aims to strengthen the marine biomedicine sector [1][2]

Core Insights - The report from the World Brand Lab ranks Fengshi Technology at 439th in the "Asia Brand 500" list for 2025, marking a rise of 17 positions from the previous year, and it is the only brand in the marine pharmaceuticals and bioproducts sector to be included [1] - Fengshi Technology has maintained its position as the global leader in krill oil sales for two consecutive years, with its VIK brand being the top-selling domestic krill oil brand in China [1][2] - The company has made significant investments in R&D, holding 49 intellectual property rights and participating in the formulation of 3 national standards and 9 group standards [1] Product Innovations - In May, Fengshi Technology launched the world's first PQQ small molecule krill peptide, which generated significant consumer interest [2] - The VIK blue hat krill oil product, which is the only domestic krill oil with dual functions of maintaining blood lipid levels and enhancing immunity, was launched in 57 Sam's Club stores nationwide [2] - The company's products are now available in 22 countries and regions, including the UK, France, Germany, and New Zealand [2] Quality and Certifications - Fengshi Technology has achieved a marine phospholipid content of 56% in its krill oil, with a leak rate controlled to below 0.01%, ensuring 100% stable quality [2] - The company has received a 100% compliance certification from the international authority ORIVO for five consecutive years, becoming the first company to achieve ORIVO's "5-year zero defect" quality gold standard certification [2] Strategic Collaborations - The company has initiated a strategic partnership with Norway's Aker to develop a lipid-lowering drug, CaPre, and has collaborated with China Pharmaceutical University on research related to marine peptides for anti-tumor and anti-aging applications [3] - Fengshi Technology aims to enhance innovation-driven development and deepen industry-academia-research cooperation to lead breakthroughs in global marine pharmaceuticals and bioproducts [3]